Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Venstrom

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2015
KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemiaJohn Marra, Justin Greene, Jimmy Hwang, et al.
JAMA|December 6, 2003
Survival after pancreas transplantation in patients with diabetes and preserved kidney functionJeffrey M Venstrom, Maureen A McBride, Kristina I Rother, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2020
Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovaryDouglas I Lin, Jonathan K Killian, Jeffrey M Venstrom, et al.
Clinical Pharmacology and Therapeutics|August 4, 2020
Evidence-Based Development and Clinical Use of Precision Oncology TherapeuticsLeah A Comment, Ashley F Ward, Alexa B Schrock, et al.
Blood|February 4, 2010
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantationJeffrey M Venstrom, Ted A Gooley, Stephen Spellman, et al.
Blood|January 31, 2009
Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantationJunli Yu, Jeffrey M Venstrom, Xiao-Rong Liu, et al.
Blood Advances|February 17, 2019
PD-L1 and tumor-associated macrophages in de novo DLBCLRonald McCord, Christopher R Bolen, Hartmut Koeppen, et al.
The Oncologist|January 19, 2021
RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR-Containing Therapy Regimens in Metastatic Colorectal CancerAlexa B Schrock, Jessica K Lee, Jaideep Sandhu, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myelomaHaibo Sun, Thomas G Martin, John Marra, et al.
JCO Precision Oncology|August 29, 2024
A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent DiseaseBrandon A Mahal, Matthew Margolis, Earl Hubbell, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2015
KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemiaJohn Marra, Justin Greene, Jimmy Hwang, et al.
JAMA|December 6, 2003
Survival after pancreas transplantation in patients with diabetes and preserved kidney functionJeffrey M Venstrom, Maureen A McBride, Kristina I Rother, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2020
Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovaryDouglas I Lin, Jonathan K Killian, Jeffrey M Venstrom, et al.
Clinical Pharmacology and Therapeutics|August 4, 2020
Evidence-Based Development and Clinical Use of Precision Oncology TherapeuticsLeah A Comment, Ashley F Ward, Alexa B Schrock, et al.
Blood|February 4, 2010
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantationJeffrey M Venstrom, Ted A Gooley, Stephen Spellman, et al.
Blood|January 31, 2009
Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantationJunli Yu, Jeffrey M Venstrom, Xiao-Rong Liu, et al.
Blood Advances|February 17, 2019
PD-L1 and tumor-associated macrophages in de novo DLBCLRonald McCord, Christopher R Bolen, Hartmut Koeppen, et al.
The Oncologist|January 19, 2021
RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR-Containing Therapy Regimens in Metastatic Colorectal CancerAlexa B Schrock, Jessica K Lee, Jaideep Sandhu, et al.
Journal for Immunotherapy of Cancer|July 17, 2021
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myelomaHaibo Sun, Thomas G Martin, John Marra, et al.
JCO Precision Oncology|August 29, 2024
A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent DiseaseBrandon A Mahal, Matthew Margolis, Earl Hubbell, et al.
Pageof 4